Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen's multiple myeloma drug falls short in late stage study
Amgen's multiple myeloma drug falls short in late stage study
Amgen's multiple myeloma drug falls short in late stage study
Submitted by
admin
on September 27, 2016 - 10:18am
Source:
Yahoo/Reuters
News Tags:
Amgen
Multiple Myeloma
Kyprolis
clinical trials
Takeda
Velcade
Headline:
Amgen's multiple myeloma drug falls short in late stage study
Do Not Allow Advertisers to Use My Personal information
